Skip to Main Content

Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI (OI)

Conditions

Children's Health

Phase III

What is the purpose of this trial?

This is a prospective, multicenter, single-arm study in children 2 to 17 years of age with OI to evaluate efficacy and safety of denosumab.

  • Trial with
    Amgen, Inc.
  • Start Date
    09/28/2017
  • End Date
    02/14/2018
Trial Image

For more information about this study, contact:

Najea Poindexter

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    02/22/2018
  • Study HIC
    #1501015168